Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruonan Jiao

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Cancer Cell International|July 18, 2020
Prognostic and clinicopathological significance of SNHG20 in human cancers: a meta-analysisHanlong Zhu, Si Zhao, Ruonan Jiao, et al.
Frontiers in Oncology|March 29, 2021
Bispecific c-Met/PD-L1 CAR-T Cells Have Enhanced Therapeutic Effects on Hepatocellular CarcinomaWei Jiang, Tao Li, Jiaojiao Guo, et al.
Cell Death Discovery|July 26, 2019
Reversal of sorafenib resistance in hepatocellular carcinoma: epigenetically regulated disruption of 14-3-3η/hypoxia-inducible factor-1αYongxin Qiu, Wenqi Shan, Ye Yang, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 22, 2018
Arsenic trioxide reverses the chemoresistance in hepatocellular carcinoma: a targeted intervention of 14-3-3η/NF-κB feedback loopYongxin Qiu, Yi Dai, Chi Zhang, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Cancer Cell International|July 18, 2020
Prognostic and clinicopathological significance of SNHG20 in human cancers: a meta-analysisHanlong Zhu, Si Zhao, Ruonan Jiao, et al.
Frontiers in Oncology|March 29, 2021
Bispecific c-Met/PD-L1 CAR-T Cells Have Enhanced Therapeutic Effects on Hepatocellular CarcinomaWei Jiang, Tao Li, Jiaojiao Guo, et al.
Cell Death Discovery|July 26, 2019
Reversal of sorafenib resistance in hepatocellular carcinoma: epigenetically regulated disruption of 14-3-3η/hypoxia-inducible factor-1αYongxin Qiu, Wenqi Shan, Ye Yang, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 22, 2018
Arsenic trioxide reverses the chemoresistance in hepatocellular carcinoma: a targeted intervention of 14-3-3η/NF-κB feedback loopYongxin Qiu, Yi Dai, Chi Zhang, et al.
Pageof 2